The global artificial saliva market (人工唾液市場) is projected to reach US$ 1.28 billion in 2024 and is expected to grow at a compound annual growth rate (CAGR) of 14.2% from 2024 to 2034. This growth is primarily attributed to the rising prevalence of conditions like Sjögren's syndrome, diabetes, and medication side effects, which lead to dry mouth. Artificial saliva products are essential for alleviating symptoms and enhancing oral health in individuals suffering from xerostomia. These products aim to replicate the natural composition of saliva, providing moisture, lubrication, and pH balance to the oral cavity.

Get Free Sample Copy of This Report:
https://www.factmr.com/connectus/sample?flag=S&rep_id=7297

Consumer preferences are shifting towards artificial saliva products containing natural and bioactive ingredients, reflecting a desire for solutions that closely mimic natural saliva composition. This trend underscores a holistic approach to oral care. Furthermore, innovations in artificial saliva formulations, including the integration of technology such as smart delivery systems or IoT-enabled devices, are anticipated to improve user experience by enabling real-time monitoring and personalized solutions.

Key Takeaways from Market Study

  • The global artificial saliva market (인공 타액 시장) is projected to reach US$ 4.82 billion by 2034-end.
  • Sales of artificial saliva products in the United States are foreseen to rise at a CAGR of 14.7% from 2024 to 2034.
  • Growing organic trend in Germany is driving high demand for natural ingredient-based artificial saliva solutions.
  • Sales of artificial saliva products in Japan are forecasted to expand at a CAGR of 10.6% through 2034.
  • Demand for artificial saliva sprays is calculated at a market value of US$ 400.5 million for 2024.

Key Companies Profiled in This Report

  • ICPA Health Products Ltd.
  • Lee BioSolutions
  • CCMed Group
  • Midatech Pharma PLC
  • Bausch Health Companies Inc.
  • Parnell Pharmaceuticals, Inc.
  • Forward Science
  • Laboratorios KIN S.A.
  • Valeant Pharmaceuticals International, Inc.
  • Biocosmetics Laboratories S.L.
  • Perrigo Company PLC
  • GlaxoSmithKline Plc
  • Cipla Inc.
  • Mission Pharmacal Company
  • Fresenius Kabi AG

Competitive Analysis

Major players in the artificial saliva market are heavily investing in research and development to improve their product formulations, giving them a competitive edge and enabling them to meet changing consumer demands. These companies are also expanding their global presence to cater to a wider customer base, which helps them generate significant profits.

For instance, in September 2021, ICPA Health Products (ICPA) introduced Wet Mouth, a product aimed at alleviating xerostomia, commonly known as dry mouth.

Get Customization on this Report for Specific Research Solutions:

https://www.factmr.com/connectus/sample?flag=RC&rep_id=7297

Key Segments Covered in Artificial Saliva Market (Markt für künstlichen Speichel) Research

  • By Product :

    • Oral Sprays

    • Oral Solutions

    • Oral Liquids

    • Gels

    • Powders

  • By Age Group :

    • Adults

    • Pediatrics

  • By Distribution Channel :

    • Hospital Pharmacies

    • Retail Pharmacies

    • Mail Order Pharmacies

    • Hypermarkets & Supermarkets

  • By Region :

    • North America

    • Latin America

    • Europe

    • East Asia

    • South Asia & Oceania

    • Middle East & Africa

About Fact.MR :

We are a trusted research partner of 80% of fortune 1000 companies across the globe. We are consistently growing in the field of market research with more than 1000 reports published every year. The dedicated team of 400-plus analysts and consultants is committed to achieving the utmost level of our client’s satisfaction.

Contact:

US Sales Office

11140 Rockville Pike

Suite 400 Rockville, MD 20852

United States Tel: +1 (628) 251-1583, +353-1-4434-232 (D)

Sales Team: sales@factmr.com